Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 12/03 01:52:19 pm
304.47 USD   +0.99%
12:15pVaccine makers could make Omicron-specific booster, says Fauci
RE
12:02pPUMP / DUMP #13 : This week's gainers and losers
01:21aUK jabs deal to 'future-proof' immunisation
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : US regulators allow mixing of COVID-19 shots for boosters and clear booster Moderna, J&J doses

10/20/2021 | 04:51pm EST

WASHINGTON (AP) — US regulators allow mixing of COVID-19 shots for boosters and clear booster Moderna, J&J doses.

Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source Associated Press News

All news about MODERNA, INC.
12:15pVaccine makers could make Omicron-specific booster, says Fauci
RE
12:02pPUMP / DUMP #13 : This week's gainers and losers
01:21aUK jabs deal to 'future-proof' immunisation
AQ
12/02Pfizer-BioNTech, Moderna's COVID-19 Jabs Offer Best Immunity Boost, UK Study Says
MT
12/02U.S. administers 464.4 mln doses of COVID-19 vaccines - CDC
RE
12/02U.S. CDC Says Delivered 578,263,565 Doses Of COVID-19 Vaccine As Of Dec 2
RE
12/02US Stocks Rebound Following Recent Sell-Offs as Omicron Variant Concerns Subside
MT
12/02Stocks Led Higher Midday by Financials, Energy; GlaxoSmithKline Says Sotrovimab Showed ..
MT
12/02What COVID-19 vaccine and drug makers have to say about Omicron
RE
12/02COVID-19 vaccines less effective in cancer patients receiving chemotherapy
AQ
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 17 449 M - -
Net income 2021 11 169 M - -
Net cash 2021 12 344 M - -
P/E ratio 2021 11,5x
Yield 2021 -
Capitalization 122 B 122 B -
EV / Sales 2021 6,30x
EV / Sales 2022 4,82x
Nbr of Employees 1 300
Free-Float 90,5%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Last Close Price 301,49 $
Average target price 272,53 $
Spread / Average Target -9,60%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.188.59%122 239
LONZA GROUP AG25.98%57 878
IQVIA HOLDINGS INC.46.64%50 192
SEAGEN INC.-9.40%29 014
CELLTRION, INC.-40.67%24 745
ICON PUBLIC LIMITED COMPANY40.04%22 226